In this issue:
Safety and efficacy of inebilizumab
FDG PET in a Chinese cohort
CAMKV encephalitis
MOG antibody testing
Real-world healthcare cost savings in MS
Efficacy of atogepant in migraine
Overcoming therapeutic challenges in MG
Correlation between severe attacks and aquaporin 4 titre
Ocrelizumab and ofatumumab comparison
Long-term disability aquaporin 4
Please login below to download this issue (PDF)